During the reported period, the company repurchased approximately $24 million of its common stock, representing approximately 929,000 shares, under its existing $2.5 billion share repurchase programme. As of November 25, 2017, the programme had a remaining balance of approximately $1.5 billion.
The company's planning assumptions reflect actual results through the fiscal third quarter and the current trends the company has been experiencing. Based upon its planning assumptions, the company continues to model net earnings per diluted share for the full year to be about $3.00. (RR)
ALCHEMPro News Desk – India
Receive daily prices and market insights straight to your inbox. Subscribe to AlchemPro Weekly!
marketing@alchempro.com
